Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.

Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.

Item
http://www.wikidata.org/entity/Q46589098
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesHigh mobility group a proteins as tumor markersClinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.A straightforward but not piecewise relationship between age and lymph node status in Chinese breast cancer patients.Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapyMolecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.Evaluation of the progesterone receptor status in breast cancer using three different antibodies: a comparison by Allred score system.St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.HMGA1 overexpression is associated with a particular subset of human breast carcinomas.Heterogeneity of breast cancer clinical characteristics and outcome in US black women--effect of place of birth.Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.
P2860

Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.

Item
http://www.wikidata.org/entity/Q46589098
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@en
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@nl
type
label
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@en
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@nl
prefLabel
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@en
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Breast cancer patients with es ...... adjuvant tamoxifen treatment.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P698